In this activity, experts in the management of HIV review important issues to consider when individualizing antiretroviral therapy. The treatment of patients with HIV and comorbid HBV, HCV, or renal insufficiency, as well as management strategies for pregnant women are featured.
In this activity, experts in the treatment of HIV present current data on initial treatment options in HIV as well as efficacy and safety data on switching strategies.
In this activity, an expert in the treatment of HIV reviews initial treatment strategies in HIV and explores issues related to switching antiretroviral therapies.
In this activity, experts in the treatment of hepatitis discuss recent data on the efficacy of oral antiviral agents in the management of chronic hepatitis B. An assessment of the long-term risk for developing viral resistance with these agents is featured.
In this activity, experts in the treatment of HIV discuss the pros and cons of initiating antiretroviral therapy earlier than what is currently recommended. Issues of safety, resistance, and tolerability that need to be considered when selecting an initial treatment strategy are featured. The impact of antiretrovirals on lipid parameters and cardiovascular risk is discussed.
In this activity, experts in the treatment of HIV discuss the incidence of HIV in adolescents and young adults. Management considerations for the treatment of HIV in young adults are featured.
In this activity, experts in the treatment of HIV review the most recent guidelines for the initiation of antiretroviral therapy in HIV. Data used as evidence for some of the updated recommendations will be featured.
In this activity, experts in the treatment of HIV present recent data on efficacy and safety of fixed-dose antiretrovirals. The incorporation of many of these agents into evidence-based guidelines is featured.
In this activity, experts in the management of hepatitis will examine recent data evaluating the use of oral nucleoside agents in the treatment of chronic hepatitis B. The occurrence of resistance with these agents will be highlighted.
Using a case-based modality, an expert in HIV will address how to use evidence-based guidelines to help improve the management of patients with HIV. The treatment of newly-diagnosed patients and patients coinfected with HIV/HBV will be featured.
In this activity, experts in HIV/AIDS present recent data on the efficacy and safety of protease inhibitor-based regimens in both treatment-naïve and -experienced patients with HIV.
In this activity, experts in the treatment of HIV present recent data on fixed-dose antiretroviral combinations for the management of this condition. The use of these agents to simplify treatment of HIV is featured.
In this activity, experts in the management of hepatitis will discuss the expanding treatment options available to treat patients with chronic hepatitis B.
In this activity, experts in the treatment of HIV present the most current data on efficacy and safety of once-daily agents and regimens used in the management of this condition.
In this activity, experts in the treatment of HIV present recent data on efficacy and safety of once-daily antiretroviral agents and once-daily regimens used in the management of this condition.
In this activity, experts in the management of HIV review special issues that one needs to consider when treating patients who are current or former injection drug users.
